시장보고서

상품코드

1629310

생체흡수성 혈관 스캐폴드 시장 : 유형별, 재료 유형별, 용도별, 최종사용자별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율, 예측(2024-2032년)

Bioresorbable Vascular Scaffold Market, By Type, By Material Type, By Application, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

발행일: 2024년 12월 | 리서치사:

AnalystView Market Insights | 페이지 정보: 영문 311 Pages | 배송안내 : 2-3일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

보고서 하이라이트

생체흡수성 혈관 스캐폴드의 시장 규모는 2023년 3억 9,850만 달러로 2024년부터 2032년까지 CAGR 8.90%로 확대될 전망입니다.

생체흡수성 혈관 스캐폴드 시장 - 시장 역학

심혈관질환의 유병률 증가로 첨단 치료법에 대한 수요 증가

심혈관질환(CVD)의 유병률 증가는 생체흡수성 혈관 스캐폴드(BVS) 시장의 주요 촉진요인으로, 전 세계적으로 CVD의 부담이 증가함에 따라 관상동맥 건강을 지원하는 BVS와 같은 고급 치료법에 대한 수요가 증가하고 있습니다. 세계보건기구(WHO)에 따르면, CVD는 세계 사망원인 1위로 연간 1,790만 명이 사망하며 전 세계 사망자의 32%를 차지합니다. 미국 질병통제예방센터(CDC)에 따르면 20세 이상 성인 중 약 1,820만 명이 관상동맥질환을 앓고 있어 BVS와 같은 혁신적인 솔루션의 필요성이 대두되고 있으며, CVD 발병률이 지속적으로 증가함에 따라 생체흡수성 비계와 같은 효과적인 최소침습적 치료법에 대한 수요가 증가하고 있습니다. 에 대한 수요가 확대되어 시장을 견인할 것으로 예상됩니다.

생체흡수성 혈관 스캐폴드 시장 - 주요 인사이트

당사의 리서치 애널리스트가 공유한 분석에 따르면, 세계 시장은 예측 기간(2024-2032년) 동안 매년 약 8.90%의 CAGR로 성장할 것으로 예상됩니다.

유형별로는 약물 용출성 생체흡수성 혈관 스캐폴드가 2023년 가장 큰 시장 점유율을 차지할 것으로 예측됐습니다.

재료 유형별로는 폴리락트산(PLA)이 2023년 주요 부문으로 부상했습니다.

용도별로는 관상동맥 질환 치료가 2023년 주요 부문으로 꼽혔습니다.

지역별로는 북미가 2023년 주요 수익원이었습니다.

생체흡수성 혈관 스캐폴드 시장 - 세분화 분석:

세계 생체흡수성 혈관 스캐폴드 시장은 유형, 재료 유형, 용도, 최종사용자 및 지역에 따라 세분화됩니다.

시장은 유형에 따라 약물 용출성 생체흡수성 혈관 스캐폴드, 비약물 용출성 생체흡수성 혈관 스캐폴드로 분류됩니다. 약물 용출성 생체흡수성 혈관 스캐폴드 부문은 생체흡수성 혈관 스캐폴드(BVS) 시장에서 가장 두드러집니다. 이 비계는 세포의 증식을 억제하여 재협착(동맥 재협착)을 방지하는 약물로 코팅되어 있어 장기적인 치료 결과를 보장하는 데 매우 효과적입니다. 약물 용출 기능이 추가되어 합병증 위험이 크게 감소하기 때문에 의료진과 환자들 사이에서 인기가 높아지고 있습니다. 관상동맥 질환 치료에서 재협착을 최소화하고 임상 결과를 개선하는 것이 점점 더 중요해지면서 약물 용출형 BVS가 선호되고 있습니다. 또한, 이러한 비계는 생체 흡수와 약물전달의 장점을 결합하여 우수한 치료 효과를 제공합니다. 이 부문의 성장은 북미와 유럽 등지에서 진행 중인 임상 연구와 다양한 약물용출형 BVS 제품의 승인에 힘입어 더욱 가속화되고 있습니다. 그 결과, 약물 용출 부문은 시장에서 우위를 유지할 것으로 예상됩니다.

시장은 재료 유형에 따라 폴리락트산(PLA), 폴리L-락트산(PLLA), 마그네슘 기반, 기타로 나뉩니다. 폴리락트산(PLA) 부문은 생체흡수성 혈관 스캐폴드(BVS) 시장에서 가장 두드러지며, PLA는 생체적합성, 생분해성, 기계적 특성으로 인해 혈관 스캐폴드로 이상적인 재료로 널리 사용되고 있습니다. 치유 과정에서 동맥을 지지하는 데 필요한 강도와 유연성을 제공하는 동시에 체내에 서서히 흡수되어 영구 스텐트에 수반되는 장기적인 합병증을 줄일 수 있습니다. 다양한 약물전달 시스템에서 사용되는 등 PLA의 의료 용도로서의 입증된 실적은 BVS 시장에서 PLA가 큰 존재감을 발휘할 수 있는 원동력이 되고 있습니다. 이 부문의 성장을 주도하는 것은 최소침습적 솔루션에 대한 수요 증가와 임상시험에서 PLA 기반 스캐폴딩 기술의 발전입니다. 입증된 효과와 유리한 특성으로 인해 PLA는 시장에서 우위를 유지할 것으로 예상됩니다.

생체흡수성 혈관 스캐폴드 시장 - 지리적 인사이트

북미는 심혈관질환의 높은 유병률과 높은 수준의 의료 인프라로 인해 생흡수성 혈관 스캐폴드(BVS) 시장의 주요 지역으로 성장하고 있습니다. 미국이 가장 큰 시장 점유율을 차지하고 있으며, Abbott Laboratories, Medtronic, Boston Scientific 등 생흡수성 비계 개발 및 보급에 적극적인 주요 의료기기 기업의 존재감이 큽니다. 이 지역은 FDA의 생체흡수성 기기 승인과 강력한 헬스케어 리베이트 정책 등 양호한 규제 환경의 혜택을 누리고 있습니다. 캐나다 역시 혁신적인 심혈관계 치료에 중점을 두면서 성장에 기여하고 있습니다. 또한, 미국과 캐나다에서는 광범위한 연구, 임상시험, 의료 서비스 제공자의 빠른 신기술 도입으로 시장 확대가 더욱 가속화되고 있습니다. 최소침습적 시술에 대한 수요 증가와 첨단 스텐트 기술의 채택은 BVS 시장에서 북미의 우위를 유지할 것으로 예상됩니다.

생체흡수성 혈관 스캐폴드 시장 - 경쟁 상황:

생체흡수성 혈관 스캐폴드(BVS) 시장의 경쟁 구도는 Abbott Laboratories, Boston Scientific Corporation, Medtronic, Biotronic 등의 주요 기업이 주도하고 있습니다. Abbott는 Absorb BVS로 잘 알려져 있으며, 고성능 비계와 광범위한 임상시험에 주력하고 있습니다. 보스턴 사이언티픽은 생체흡수성 비계 기술을 발전시키고 임상 결과 개선에 중점을 두고 있습니다. 메드트로닉은 BVS를 포함한 다양한 심혈관 솔루션으로 혁신을 거듭하고 있으며, 바이오트로닉은 혈관 중재시술에 특화되어 있으며, 기기의 안전성과 유효성을 향상시키기 위한 임상 연구에 투자하고 있습니다. 이들 기업은 기술 혁신, 임상 증거 확대, 규제 당국의 승인 확보를 통해 시장을 선도하기 위해 경쟁하고 있습니다.

소개
북미
- 개요
- 북미의 주요 제조업체
- 미국
- 캐나다
유럽
- 개요
- 유럽의 주요 제조업체
- 독일
- 이탈리아
- 영국
- 프랑스
- 러시아
- 네덜란드
- 스웨덴
- 폴란드
- 기타
아시아태평양
- 개요
- 아시아태평양의 주요 제조업체
- 인도
- 중국
- 일본
- 한국
- 호주
- 태국
- 인도네시아
- 필리핀
- 기타
라틴아메리카
- 개요
- 라틴아메리카의 주요 제조업체
- 브라질
- 멕시코
- 아르헨티나
- 콜롬비아
- 기타
중동 및 아프리카
- 개요
- 중동 및 아프리카의 주요 제조업체
- 사우디아라비아
- 아랍에미리트
- 이스라엘
- 터키
- 알제리
- 이집트
- 기타

제12장 주요 벤더 분석 - 생체흡수성 혈관 스캐폴드 업계

경쟁 대시보드
- 경쟁 벤치마크
- 경쟁 포지셔닝
기업 개요
- Abbott Laboratories
- Boston Scientific Corporation
- Medtronic
- Biotronik
- Terumo Corporation
- Stratmotive Technologies(SMT)
- Reva Medical
- Koninklijke Philips
- MIV Therapeutics
- Stentys
- Biocube
- Bioabsorbable Vascular Scaffold Solutions(BVSS)
- Vascular Concepts
- Elixir Medical
- KalliTech
- Endologix
- Camtech

제13장 애널리스트의 전방위 전망

ksm 25.02.03

REPORT HIGHLIGHT

The Bioresorbable Vascular Scaffold Market size was valued at USD 398.50 Million in 2023, expanding at a CAGR of 8.90% from 2024 to 2032.

The bioresorbable vascular scaffold market focuses on devices designed to treat coronary artery disease by temporarily supporting blood vessels and gradually dissolving over time. These scaffolds, made from biocompatible materials, provide a solution to traditional stents by eventually being absorbed by the body. The growing prevalence of cardiovascular diseases and the demand for less invasive, more efficient treatments are driving the market. Technological advancements in scaffold materials and minimally invasive procedures further contribute to its growth. Despite this, challenges such as high costs and concerns about long-term clinical outcomes compared to traditional metallic stents are hindering widespread adoption. The North American and European markets are dominant, while Asia Pacific is experiencing rapid growth due to better healthcare access and rising awareness.

Bioresorbable Vascular Scaffold Market- Market Dynamics

The increasing prevalence of cardiovascular diseases drives demand for advanced treatments.

The increasing prevalence of cardiovascular diseases (CVD) is a key driver for the bioresorbable vascular scaffold (BVS) market. As the global burden of CVD rises, there is a greater need for advanced treatments like BVS to support coronary artery health. According to the World Health Organization (WHO), CVDs are the leading cause of death globally, responsible for an estimated 17.9 million deaths annually, which accounts for 32% of all global deaths. In the United States, the Centers for Disease Control and Prevention (CDC) reports that nearly 18.2 million adults aged 20 and older have coronary artery disease, highlighting the need for innovative solutions such as BVS. As the incidence of CVD continues to rise, the demand for effective, minimally invasive treatments like bioresorbable scaffolds is expected to grow, driving the market forward.

Bioresorbable Vascular Scaffold Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 8.90% over the forecast period (2024-2032)

Based on Type segmentation, drug-eluting bioresorbable vascular scaffold was predicted to show maximum market share in the year 2023

Based on Material Type segmentation, Polylactic Acid (PLA) was the leading segment in 2023

Based on Application segmentation, Coronary Artery Disease Treatment was the leading segment in 2023

based on region, North America was the leading revenue generator in 2023

Bioresorbable Vascular Scaffold Market- Segmentation Analysis:

The Global Bioresorbable Vascular Scaffold Market is segmented based on Type, Material Type, Application, End-User, and Region.

The market is divided into three categories based on Type: Drug-eluting bioresorbable vascular scaffold, non-drug-eluting bioresorbable vascular scaffold. The drug-eluting bioresorbable vascular scaffold segment is the most prominent in the bioresorbable vascular scaffold (BVS) market. These scaffolds are coated with medications that help prevent restenosis (re-narrowing of the artery) by inhibiting cell growth, making them highly effective in ensuring long-term treatment outcomes. The addition of drug-eluting capabilities significantly reduces the risk of complications, which has made these scaffolds more popular among healthcare providers and patients. As coronary artery disease treatments increasingly focus on minimizing restenosis and improving clinical results, drug-eluting BVSs are gaining preference. Moreover, these scaffolds combine the benefits of both biosorption and drug delivery, providing superior therapeutic efficacy. This segment's growth is further supported by ongoing clinical studies and the successful approval of various drug-eluting BVS products in regions like North America and Europe. Consequently, the drug-eluting segment is expected to remain dominant in the market.

The market is divided into two categories based on Material Type: Polylactic Acid (PLA), Poly-L-lactic Acid (PLLA), Magnesium-Based, and Others. The Polylactic Acid (PLA) segment is the most prominent in the bioresorbable vascular scaffold (BVS) market. PLA is widely used due to its biocompatibility, biodegradability, and mechanical properties that make it an ideal material for vascular scaffolds. It offers the necessary strength and flexibility required to support the artery during the healing process, while also gradually resorbing into the body, reducing long-term complications associated with permanent stents. PLA's established track record in medical applications, including its use in various drug delivery systems, contributes to its significant presence in the BVS market. The segment's growth is driven by the increasing demand for minimally invasive solutions and the advancement of PLA-based scaffold technologies in clinical trials. Given its proven effectiveness and favorable properties, PLA is expected to maintain its dominance in the market.

Bioresorbable Vascular Scaffold Market- Geographical Insights

North America is the leading region in the bioresorbable vascular scaffold (BVS) market, driven by the high incidence of cardiovascular diseases and advanced healthcare infrastructure. The United States holds the largest market share, supported by a strong presence of leading medical device companies such as Abbott Laboratories, Medtronic, and Boston Scientific, which are actively developing and promoting bioresorbable scaffolds. The region benefits from favorable regulatory environments, including the FDA's approval of bioresorbable devices, along with strong healthcare reimbursement policies. Canada also contributes to the growth, with a growing emphasis on innovative cardiovascular treatments. Additionally, extensive research, clinical trials, and early adoption of new technologies by healthcare providers in the U.S. and Canada further fuel market expansion. The increasing demand for minimally invasive procedures and the adoption of advanced stent technologies are expected to maintain North America's dominance in the BVS market.

Bioresorbable Vascular Scaffold Market- Competitive Landscape:

The competitive landscape of the bioresorbable vascular scaffold (BVS) market is dominated by key players such as Abbott Laboratories, Boston Scientific Corporation, Medtronic, and Biotronik. Abbott is recognized for its Absorb BVS, focusing on high-performance scaffolds and extensive clinical trials. Boston Scientific is advancing bioresorbable scaffold technology, emphasizing improved clinical outcomes. Medtronic continues to innovate with a range of cardiovascular solutions, including BVS, while Biotronik specializes in vascular interventions and invests in clinical studies to enhance device safety and effectiveness. These companies are competing to lead the market by innovating, expanding clinical evidence, and securing regulatory approvals.

Recent Developments:

In April 2024, the FDA approved Abbott's Esprit BTK, an everolimus-eluting bioresorbable scaffold, for the treatment of patients with below-the-knee (BTK) infra popliteal disease. This approval marks the first-ever device authorized by the FDA specifically for BTK lesions. The decision was based on the positive results from the LIFE-BTK study, which showed reduced risks of amputation, vessel occlusion, revascularization, and restenosis compared to conventional angioplasty.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL BIORESORBABLE VASCULAR SCAFFOLD MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Abbott Laboratories
Boston Scientific Corporation
Medtronic
Biotronik
Terumo Corporation
Stratmotive Technologies (SMT)
Reva Medical
Koninklijke Philips
MIV Therapeutics
Stentys
Biocube
Bioabsorbable Vascular Scaffold Solutions (BVSS)
Vascular Concepts
Elixir Medical
KalliTech
Endologix
Camtech

GLOBAL BIORESORBABLE VASCULAR SCAFFOLD MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

Drug-eluting bioresorbable Vascular Scaffold
Non-Drug-Eluting Bioresorbable Vascular Scaffold

GLOBAL BIORESORBABLE VASCULAR SCAFFOLD MARKET, BY MATERIAL TYPE- MARKET ANALYSIS, 2019 - 2032

Polylactic Acid (PLA)
Poly-L-lactic Acid (PLLA)
Magnesium-Based
Others

GLOBAL BIORESORBABLE VASCULAR SCAFFOLD MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

Coronary Artery Disease Treatment
Peripheral Artery Disease Treatment
Others

GLOBAL BIORESORBABLE VASCULAR SCAFFOLD MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

Hospitals
Ambulatory Surgical Centers
Cardiac Catheterization Laboratories
Others

GLOBAL BIORESORBABLE VASCULAR SCAFFOLD MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA

1. Bioresorbable Vascular Scaffold Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. Bioresorbable Vascular Scaffold Market Snippet by Type
- 2.1.2. Bioresorbable Vascular Scaffold Market Snippet by Material Type
- 2.1.3. Bioresorbable Vascular Scaffold Market Snippet by Application
- 2.1.4. Bioresorbable Vascular Scaffold Market Snippet by End-User
- 2.1.5. Bioresorbable Vascular Scaffold Market Snippet by Country
- 2.1.6. Bioresorbable Vascular Scaffold Market Snippet by Region
2.2. Competitive Insights

3. Bioresorbable Vascular Scaffold Key Market Trends

3.1. Bioresorbable Vascular Scaffold Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. Bioresorbable Vascular Scaffold Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. Bioresorbable Vascular Scaffold Market Opportunities
3.4. Bioresorbable Vascular Scaffold Market Future Trends

4. Bioresorbable Vascular Scaffold Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. Bioresorbable Vascular Scaffold Market: Impact of Escalating Geopolitical Tensions

5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts

6. Bioresorbable Vascular Scaffold Market Landscape

6.1. Bioresorbable Vascular Scaffold Market Share Analysis, 2023
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. Bioresorbable Vascular Scaffold Market - By Type

7.1. Overview
- 7.1.1. Segment Share Analysis, By Type, 2023 & 2032 (%)
- 7.1.2. Drug-eluting bioresorbable Vascular Scaffold
- 7.1.3. Non-Drug-Eluting Bioresorbable Vascular Scaffold

8. Bioresorbable Vascular Scaffold Market - By Material Type

8.1. Overview
- 8.1.1. Segment Share Analysis, By Material Type, 2023 & 2032 (%)
- 8.1.2. Polylactic Acid (PLA)
- 8.1.3. Poly-L-lactic Acid (PLLA)
- 8.1.4. Magnesium-Based
- 8.1.5. Others

9. Bioresorbable Vascular Scaffold Market - By Application

9.1. Overview
- 9.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
- 9.1.2. Coronary Artery Disease Treatment
- 9.1.3. Peripheral Artery Disease Treatment
- 9.1.4. Others

10. Bioresorbable Vascular Scaffold Market - By End-User

10.1. Overview
- 10.1.1. Segment Share Analysis, By End-User, 2023 & 2032 (%)
- 10.1.2. Hospitals
- 10.1.3. Ambulatory Surgical Centers
- 10.1.4. Cardiac Catheterization Laboratories
- 10.1.5. Others

11. Bioresorbable Vascular Scaffold Market- By Geography

11.1. Introduction
- 11.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
11.2. North America
- 11.2.1. Overview
- 11.2.2. Bioresorbable Vascular Scaffold Key Manufacturers in North America
- 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 11.2.5. North America Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
- 11.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.2.7. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.2.8. The U.S.
  - 11.2.8.1. Overview
  - 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.2.8.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.2.8.4. U.S. Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
  - 11.2.8.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.2.8.6. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.2.9. Canada
  - 11.2.9.1. Overview
  - 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.2.9.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.2.9.4. Canada Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
  - 11.2.9.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.2.9.6. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.3. Europe
- 11.3.1. Overview
- 11.3.2. Bioresorbable Vascular Scaffold Key Manufacturers in Europe
- 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 11.3.5. Europe Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
- 11.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.7. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.3.8. Germany
  - 11.3.8.1. Overview
  - 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.8.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.3.8.4. Germany Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
  - 11.3.8.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.8.6. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.3.9. Italy
  - 11.3.9.1. Overview
  - 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.9.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.3.9.4. Italy Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
  - 11.3.9.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.9.6. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.3.10. United Kingdom
  - 11.3.10.1. Overview
  - 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.10.3. United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.3.10.4. United Kingdom Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
  - 11.3.10.5. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.10.6. United Kingdom Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.3.11. France
  - 11.3.11.1. Overview
  - 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.11.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.3.11.4. France Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
  - 11.3.11.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.11.6. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.3.12. Russia
  - 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.12.2. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.3.12.3. Russia Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
  - 11.3.12.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.12.5. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.3.13. Netherlands
  - 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.13.2. Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.3.13.3. Netherlands Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
  - 11.3.13.4. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.13.5. Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.3.14. Sweden
  - 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.14.2. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.3.14.3. Sweden Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
  - 11.3.14.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.14.5. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.3.15. Poland
  - 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.15.2. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.3.15.3. Poland Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
  - 11.3.15.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.15.5. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.3.16. Rest of Europe
  - 11.3.16.1. Overview
  - 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.16.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.3.16.4. Rest of the Europe Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
  - 11.3.16.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.16.6. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.4. Asia Pacific (APAC)
- 11.4.1. Overview
- 11.4.2. Bioresorbable Vascular Scaffold Key Manufacturers in Asia Pacific
- 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.4.4. Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 11.4.5. Asia Pacific Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
- 11.4.6. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.7. Asia Pacific Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.4.8. India
  - 11.4.8.1. Overview
  - 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.8.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.4.8.4. India Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
  - 11.4.8.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.8.6. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.4.9. China
  - 11.4.9.1. Overview
  - 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.9.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.4.9.4. China Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
  - 11.4.9.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.9.6. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.4.10. Japan
  - 11.4.10.1. Overview
  - 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.10.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.4.10.4. Japan Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
  - 11.4.10.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.10.6. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.4.11. South Korea
  - 11.4.11.1. Overview
  - 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.11.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.4.11.4. South Korea Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
  - 11.4.11.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.11.6. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.4.12. Australia
  - 11.4.12.1. Overview
  - 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.12.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.4.12.4. Australia Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
  - 11.4.12.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.12.6. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.4.13. Thailand
  - 11.4.13.1. Overview
  - 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.13.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.4.13.4. Thailand Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
  - 11.4.13.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.13.6. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.4.14. Indonesia
  - 11.4.14.1. Overview
  - 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.14.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.4.14.4. Indonesia Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
  - 11.4.14.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.14.6. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.4.15. Philippines
  - 11.4.15.1. Overview
  - 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.15.3. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.4.15.4. Philippines Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
  - 11.4.15.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.15.6. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.4.16. Rest of APAC
  - 11.4.16.1. Overview
  - 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.16.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.4.16.4. Rest of APAC Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
  - 11.4.16.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.16.6. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.5. Latin America
- 11.5.1. Overview
- 11.5.2. Bioresorbable Vascular Scaffold Key Manufacturers in Latin America
- 11.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.5.4. Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 11.5.5. Latin America Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
- 11.5.6. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.5.7. Latin America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.5.8. Brazil
  - 11.5.8.1. Overview
  - 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.8.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.5.8.4. Brazil Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
  - 11.5.8.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.5.8.6. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.5.9. Mexico
  - 11.5.9.1. Overview
  - 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.9.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.5.9.4. Mexico Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
  - 11.5.9.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.5.9.6. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.5.10. Argentina
  - 11.5.10.1. Overview
  - 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.10.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.5.10.4. Argentina Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
  - 11.5.10.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.5.10.6. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.5.11. Colombia
  - 11.5.11.1. Overview
  - 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.11.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.5.11.4. Colombia Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
  - 11.5.11.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.5.11.6. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.5.12. Rest of LATAM
  - 11.5.12.1. Overview
  - 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.12.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.5.12.4. Rest of LATAM Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
  - 11.5.12.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.5.12.6. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.6. Middle East and Africa
- 11.6.1. Overview
- 11.6.2. Bioresorbable Vascular Scaffold Key Manufacturers in the Middle East and Africa
- 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.6.4. Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 11.6.5. Middle East and Africa Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
- 11.6.6. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.6.7. Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.6.8. Saudi Arabia
  - 11.6.8.1. Overview
  - 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.8.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.6.8.4. Saudi Arabia Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
  - 11.6.8.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.6.8.6. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.6.9. United Arab Emirates
  - 11.6.9.1. Overview
  - 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.9.3. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.6.9.4. United Arab Emirates Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
  - 11.6.9.5. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.6.9.6. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.6.10. Israel
  - 11.6.10.1. Overview
  - 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.10.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.6.10.4. Israel Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
  - 11.6.10.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.6.10.6. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.6.11. Turkey
  - 11.6.11.1. Overview
  - 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.11.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.6.11.4. Turkey Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
  - 11.6.11.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.6.11.6. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.6.12. Algeria
  - 11.6.12.1. Overview
  - 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.12.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.6.12.4. Algeria Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
  - 11.6.12.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.6.12.6. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.6.13. Egypt
  - 11.6.13.1. Overview
  - 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.13.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.6.13.4. Egypt Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
  - 11.6.13.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.6.13.6. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.6.14. Rest of MEA
  - 11.6.14.1. Overview
  - 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.14.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.6.14.4. Rest of MEA Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
  - 11.6.14.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.6.14.6. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Bioresorbable Vascular Scaffold Industry

12.1. Competitive Dashboard
- 12.1.1. Competitive Benchmarking
- 12.1.2. Competitive Positioning
12.2. Company Profiles
- 12.2.1. Abbott Laboratories
- 12.2.2. Boston Scientific Corporation
- 12.2.3. Medtronic
- 12.2.4. Biotronik
- 12.2.5. Terumo Corporation
- 12.2.6. Stratmotive Technologies (SMT)
- 12.2.7. Reva Medical
- 12.2.8. Koninklijke Philips
- 12.2.9. MIV Therapeutics
- 12.2.10. Stentys
- 12.2.11. Biocube
- 12.2.12. Bioabsorbable Vascular Scaffold Solutions (BVSS)
- 12.2.13. Vascular Concepts
- 12.2.14. Elixir Medical
- 12.2.15. KalliTech
- 12.2.16. Endologix
- 12.2.17. Camtech

13. 360 Degree Analyst View

14. Appendix

14.1. Research Methodology
14.2. References
14.3. Abbreviations
14.4. Disclaimer
14.5. Contact Us